Targeting the provirus in HIV-1 latently infected cells with a cell-activation-inducible CRISPR-Cas9 system: An in vitro proof of concept

Molecular Therapy: Nucleic Acids · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles